Bridget Fisher is a PhD candidate in the Department of Infectious Diseases at The University of Melbourne. Her research focuses on the development of mRNA and lipid nanoparticle technologies for as a next-generation HIV cure therapeutic.

Laura Rikard-Bell is a first-year PhD student investigating approaches to identify, target, and eliminate HIV infected cells to support HIV cure strategies. She is particularly interested in non-T-cell reservoirs, HIV latency, and immunological mechanisms that sustain cellular reservoirs, with her research aiming to inform translational efforts toward clearing persistent HIV.

Graduate Researcher investigating novel HIV cure compounds and novel sequencing techniques to characterise HIV.

I am a PhD candidate at the Westmead Institute for Medical Research. My research focus is characterising human anogenital tissue CD4+ T cells and their susceptibility to HIV. I aim to investigate the initial establishment of HIV infection within anogenital tissues, using both wet-lab models and computational analysis.

Dr Michael Moso is an infectious diseases physician and clinician scientist based at The Peter Doherty Institute and The Royal Melbourne Hospital in Melbourne, Australia. His current research involves development of novel therapeutics to target the HIV latent reservoir using mRNA and lipid nanoparticle technology.

Leonard Mvaya is an immunologist and postdoctoral researcher at the Westmead Institute for Medical Research. His work focuses on developing novel strategies to reactivate latent HIV in CD4+ T cells in line with "shock and kill" HIV cure strategies.